Stock Agreements in the Biotechnology Industry
3,894 Contracts & Agreements
- 4D Molecular Therapeutics Inc (2 contracts)
- 89bio, Inc. (2)
- AbbVie Inc. (26)
- ABEONA THERAPEUTICS INC. (4)
- ACADIA PHARMACEUTICALS INC (4)
- ACCELERON PHARMA INC (4)
- Accustem Sciences Inc. (2)
- Achaogen, Inc. (6)
- ACHIEVE LIFE SCIENCES, INC. (8)
- Acorda Therapeutics (13)
- Actinium Pharmaceuticals, Inc. (16)
- Acumen Pharmaceuticals, Inc. (2)
- Acurx Pharmaceuticals, LLC (1)
- Adagio Therapeutics, Inc. (4)
- Adamas Pharmaceuticals Inc (6)
- Adhera Therapeutics, Inc. (12)
- ADiTx Therapeutics, Inc. (2)
- ADMA BIOLOGICS, INC. (6)
- ADURO BIOTECH, INC. (7)
- Advaxis, Inc. (9)
- Adverum Biotechnologies, Inc. (6)
- Aeglea BioTherapeutics, Inc. (13)
- Aerovate Therapeutics, Inc. (2)
- AGENUS INC (15)
- AgeX Therapeutics, Inc. (4)
- AGIOS PHARMACEUTICALS INC (4)
- AILERON THERAPEUTICS INC (2)
- Aimmune Therapeutics, Inc. (7)
- AKCEA THERAPEUTICS, INC. (3)
- Akebia Therapeutics, Inc. (6)
- Akero Therapeutics, Inc. (4)
- Akouos, Inc. (12)
- ALBIREO PHARMA, INC. (10)
- Aldeyra Therapeutics, Inc. (3)
- Alector, Inc. (4)
- Alexion Pharmaceuticals (8)
- Aligos Therapeutics, Inc. (2)
- Allakos Inc. (4)
- Allarity Therapeutics, Inc. (3)
- Allena Pharmaceuticals, Inc. (2)
- Alliqua BioMedical, Inc. (31)
- Allogene Therapeutics, Inc. (4)
- Allovir, Inc. (4)
- ALNYLAM PHARMACEUTICALS, INC. (23)
- Alpha Healthcare Acquisition Corp. (10)
- ALPINE IMMUNE SCIENCES, INC. (15)
- Altimmune, Inc. (7)
- ALX ONCOLOGY HOLDINGS INC (2)
- AMARILLO BIOSCIENCES INC (10)
- AMARIN CORP PLC (8)
- Amgen Inc. (10)
- AMICUS THERAPEUTICS, INC. (10)
- AmpliPhi Biosciences Corp (4)
- Amplitude Healthcare Acquisition Corp (5)
- ANAPTYSBIO INC (1)
- ANAVEX LIFE SCIENCES CORP. (3)
- Anika Therapeutics (3)
- Anixa Biosciences Inc (6)
- Annexon, Inc. (6)
- Annovis Bio, Inc. (1)
- Apellis Pharmaceuticals, Inc. (3)
- APPLIED GENETIC TECHNOLOGIES CORP (2)
- Applied Molecular Transport Inc. (3)
- Applied Therapeutics Inc. (2)
- Aprea Therapeutics, Inc. (4)
- Aptevo Therapeutics Inc. (2)
- Aptinyx Inc. (1)
- AQUINOX PHARMACEUTICALS, INC (3)
- Aravive, Inc. (5)
- Arbutus Biopharma Corp (2)
- ARCA biopharma, Inc. (15)
- Arcellx, Inc. (7)
- Arcturus Therapeutics Holdings Inc. (3)
- Arcus Biosciences, Inc. (7)
- Arcutis Biotherapeutics, Inc. (3)
- ARDELYX, INC. (1)
- ARENA PHARMACEUTICALS INC (15)
- Aridis Pharmaceuticals, Inc. (1)
- ARROWHEAD PHARMACEUTICALS, INC. (20)
- Arsanis, Inc. (5)
- Artiva Biotherapeutics, Inc. (2)
- ARYA Sciences Acquisition Corp II (3)
- ASSEMBLY BIOSCIENCES, INC. (9)
- Atara Biotherapeutics, Inc. (6)
- Athenex, Inc. (4)
- ATHERSYS, INC (11)
- ATOSSA GENETICS INC (10)
- Atreca, Inc. (5)
- aTYR PHARMA INC (10)
- Aura Biosciences, Inc. (3)
- Aurinia Pharmaceuticals Inc. (1)
- AVEO PHARMACEUTICALS INC (13)
- Avid Bioservices, Inc. (6)
- Avidity Biosciences, Inc. (2)
- Avita Therapeutics, Inc. (4)
- AVROBIO, Inc. (3)
- Axcella Health Inc. (2)
- Axovant Sciences Ltd. (1)
- Ayala Pharmaceuticals, Inc. (1)
- AZIYO BIOLOGICS, INC. (8)
- AzurRx BioPharma, Inc. (3)
- BCTG Acquisition Corp. (8)
- Beam Therapeutics Inc. (7)
- BELLICUM PHARMACEUTICALS, INC (2)
- Big Cypress Acquisition Corp. (3)
- BIO-PATH HOLDINGS INC (1)
- bioAffinity Technologies, Inc. (1)
- BioAtla, Inc. (11)
- BioCardia, Inc. (4)
- BIOCEPT INC (10)
- BIOCRYST PHARMACEUTICALS INC (9)
- Biogen Inc. (22)
- Biohaven Pharmaceutical Holding Co Ltd. (2)
- BioLife4D Corp (3)
- BIOMARIN PHARMACEUTICAL INC (11)
- Biomea Fusion, Inc. (2)
- BioNexus Gene Lab Coporation (2)
- BioRestorative Therapies, Inc. (23)
- BIOSPECIFICS TECHNOLOGIES CORP (7)
- Biostage, Inc. (3)
- BIOTIME INC (30)
- BIOVIE INC. (2)
- BioXcel Therapeutics, Inc. (2)
- BIOXYTRAN, INC (4)
- Black Diamond Therapeutics, Inc. (3)
- Blue Water Vaccines Inc. (2)
- bluebird bio, Inc. (4)
- Blueprint Medicines Corp (3)
- Bolt Biotherapeutics, Inc. (2)
- Bone Biologics Corp (7)
- BRAINSTORM CELL THERAPEUTICS INC. (4)
- BriaCell Therapeutics Corp. (1)
- BridgeBio Pharma, Inc. (8)
- BullFrog AI Holdings, Inc. (1)
- BURZYNSKI RESEARCH INSTITUTE INC (1)
- C4 Therapeutics, Inc. (4)
- Cabaletta Bio, Inc. (4)
- CALADRIUS BIOSCIENCES, INC. (13)
- Calithera Biosciences, Inc. (4)
- Calyxt, Inc. (2)
- CANCER GENETICS, INC (13)
- Candel Therapeutics, Inc. (3)
- CAPRICOR THERAPEUTICS, INC. (15)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (5)
- Capstone Therapeutics Corp. (5)
- CareDx, Inc. (2)
- Caribou Biosciences, Inc. (5)
- CASI Pharmaceuticals, Inc. (7)
- CASTLE BIOSCIENCES INC (7)
- CATABASIS PHARMACEUTICALS INC (5)
- CATALYST BIOSCIENCES, INC. (12)
- CATALYST PHARMACEUTICALS, INC. (12)
- CEL SCI CORP (2)
- Celcuity Inc. (2)
- Cell Source, Inc. (3)
- Celldex Therapeutics, Inc. (14)
- Cellectar Biosciences, Inc. (17)
- Cellular Biomedicine Group, Inc. (9)
- Celsion CORP (8)
- Centessa Pharmaceuticals Ltd (1)
- Century Therapeutics, Inc. (12)
- CEREBAIN BIOTECH CORP. (5)
- Chanticleer Holdings, Inc. (9)
- Chardan Healthcare Acquisition 2 Corp. (4)
- Chardan Healthcare Acquisition Corp. (3)
- Checkmate Pharmaceuticals, Inc. (4)
- Chelsea Worldwide Inc. (1)
- ChemoCentryx, Inc. (9)
- CHIMERIX INC (4)
- Cibus Global, Ltd. (5)
- Cidara Therapeutics, Inc. (5)
- CLEVELAND BIOLABS INC (4)
- Clovis Oncology, Inc. (4)
- CM Life Sciences III Inc. (6)
- Codiak BioSciences, Inc. (6)
- CohBar, Inc. (1)
- Coherus BioSciences, Inc. (4)
- Comera Life Sciences Holdings, Inc. (1)
- Conatus Pharmaceuticals Inc. (10)
- CONCERT PHARMACEUTICALS, INC. (4)
- Consonance-HFW Acquisition Corp. (3)
- Constellation Alpha Capital Corp. (7)
- CONSTELLATION PHARMACEUTICALS INC (2)
- CONTRAFECT Corp (7)
- Corbus Pharmaceuticals Holdings, Inc. (4)
- Cortexyme, Inc. (6)
- Crinetics Pharmaceuticals, Inc. (2)
- CRISPR Therapeutics AG (2)
- CTI BIOPHARMA CORP (6)
- Cue Biopharma, Inc. (3)
- Cullinan Oncology, LLC (3)
- Curative Biotechnology Inc (10)
- CURIS INC (13)
- Cyclacel Pharmaceuticals, Inc. (9)
- Cyclerion Therapeutics, Inc. (5)
- CytoDyn Inc. (18)
- Cytokinetics, Incorporated (14)
- CytomX Therapeutics, Inc. (2)
- CYTORI THERAPEUTICS, INC. (21)
- CYTRX CORP (9)
- Day One Biopharmaceuticals Holding Co LLC (3)
- DBV Technologies S.A. (3)
- Decibel Therapeutics, Inc. (4)
- DECIPHER BIOSCIENCES, INC. (2)
- Deciphera Pharmaceuticals, Inc. (4)
- DelMar Pharmaceuticals, Inc. (4)
- Denali Therapeutics Inc. (12)
- Dermira, Inc. (3)
- Design Therapeutics, Inc. (4)
- DiaMedica Therapeutics Inc. (3)
- Dicerna Pharmaceuticals Inc (11)
- Diffusion Pharmaceuticals Inc. (10)
- Digital Development Partners, Inc. (1)
- DYADIC INTERNATIONAL INC (2)
- Dynamics Special Purpose Corp. (5)
- DYNAVAX TECHNOLOGIES CORP (9)
- Dyne Therapeutics, Inc. (3)
- Eagle Pharmaceuticals, Inc. (5)
- Edge Therapeutics, Inc. (4)
- Editas Medicine, Inc. (6)
- Eidos Therapeutics, Inc. (2)
- Eiger BioPharmaceuticals, Inc. (6)
- Elevation Oncology, Inc. (2)
- Eliem Therapeutics, Inc. (2)
- Emerald Bioscience, Inc. (6)
- Emergent BioSolutions Inc. (21)
- Enanta Pharmaceuticals, Inc. (4)
- ENDONOVO THERAPEUTICS, INC. (3)
- Enochian Biosciences Inc (2)
- Entasis Therapeutics Holdings Inc. (4)
- Entrada Therapeutics, Inc. (3)
- Environmental Impact Acquisition Corp (6)
- ENZON PHARMACEUTICALS, INC. (1)
- Epizyme, Inc. (6)
- Equillium, Inc. (4)
- Erasca, Inc. (3)
- Esperion Therapeutics, Inc. (6)
- ESSA Pharma Inc. (4)
- Evelo Biosciences, Inc. (5)
- EVOLUTIONARY GENOMICS, INC. (2)
- EXACT SCIENCES CORP (9)
- Exelixis (15)
- EXICURE, INC. (2)
- FATE THERAPEUTICS INC (5)
- FENNEC PHARMACEUTICALS INC. (3)
- Fibrocell Science, Inc. (7)
- FIBROGEN INC (4)
- Finch Therapeutics Group, Inc. (3)
- FIVE PRIME THERAPEUTICS INC (4)
- Flex Pharma, Inc. (7)
- Flexion Therapeutics Inc (5)
- FLUOROPHARMA MEDICAL, INC. (3)
- Foghorn Therapeutics Inc. (3)
- Forma Therapeutics Holdings, Inc., (2)
- Fortress Biotech, Inc. (11)
- Forty Seven, Inc. (2)
- Frequency Therapeutics, Inc. (5)
- FS Development Corp. (9)
- FS Development Corp. II (5)
- G1 Therapeutics, Inc. (1)
- Gain Therapeutics, Inc. (3)
- GALECTIN THERAPEUTICS INC (11)
- Galecto Inc. (4)
- Galera Therapeutics, Inc. (2)
- Gemphire Therapeutics Inc. (5)
- Gene Biotherapeutics, Inc. (3)
- GENELUX CORP (7)
- Generation Bio Co. (3)
- GENEREX BIOTECHNOLOGY CORP (35)
- GENOCEA BIOSCIENCES, INC. (4)
- Genprex, Inc. (5)
- GeoVax Labs, Inc. (23)
- GERON CORP (20)
- Gilead Sciences (27)
- Global Blood Therapeutics, Inc. (3)
- GLYCOMIMETICS INC (4)
- Gossamer Bio, Inc. (5)
- Grail, Inc. (1)
- Graphite Bio, Inc. (4)
- Greenwich LifeSciences, Inc. (1)
- Gritstone Oncology, Inc. (5)
- GT Biopharma, Inc. (7)
- GTX INC (16)
- GX Acquisition Corp. (3)
- HALOZYME THERAPEUTICS INC (25)
- HARBOR DIVERSIFIED, INC. (7)
- Harpoon Therapeutics, Inc. (5)
- HCW Biologics Inc. (3)
- Health Sciences Acquisitions Corp (6)
- HEAT BIOLOGICS, INC. (15)
- HedgePath Pharmaceuticals, Inc. (2)
- HEMISPHERX BIOPHARMA INC (12)
- HERON THERAPEUTICS, INC. (2)
- HilleVax, Inc. (2)
- Hillstream BioPharma Inc. (1)
- HISTOGENICS CORP (13)
- Homology Medicines, Inc. (6)
- HOOKIPA Pharma Inc. (5)
- HST Global, Inc. (1)
- HUMANIGEN, INC (4)
- iBio, Inc. (6)
- Icosavax, Inc. (2)
- IDEAYA Biosciences, Inc. (6)
- IDERA PHARMACEUTICALS, INC. (20)
- IGM Biosciences, Inc. (10)
- Imago BioSciences, Inc. (2)
- Immix Biopharma, Inc. (5)
- IMMUCELL CORP (2)
- IMMUNE PHARMACEUTICALS INC (9)
- Immune Therapeutics, Inc. (3)
- Immuneering Corp (2)
- ImmunoCellular Therapeutics, Ltd. (6)
- IMMUNOGEN INC (13)
- Immunome Inc. (4)
- IMMUNOMEDICS INC (17)
- IMPEL NEUROPHARMA INC (2)
- IN8BIO, INC. (2)
- Incyte (21)
- INFINITY PHARMACEUTICALS, INC. (17)
- Inhibikase Therapeutics, Inc. (2)
- Inhibrx, Inc. (2)
- InMed Pharmaceuticals Inc. (2)
- Inmune Bio, Inc. (3)
- Innovation Pharmaceuticals Inc. (10)
- INOVIO PHARMACEUTICALS, INC. (9)
- Inozyme Pharma, Inc. (3)
- INSMED Inc (5)
- Inspyr Therapeutics, Inc. (9)
- Instil Bio, Inc. (1)
- Intellia Therapeutics, Inc. (4)
- INTERCEPT PHARMACEUTICALS, INC. (16)
- International Stem Cell CORP (16)
- INTREXON CORP (10)
- Intrinsic Medicine, Inc. (3)
- Invitae Corp (5)
- IO Biotech, Inc. (2)
- IONIS PHARMACEUTICALS INC (8)
- IOVANCE BIOTHERAPEUTICS, INC. (13)
- IRONWOOD PHARMACEUTICALS INC (5)
- Isoray, Inc. (20)
- iTeos Therapeutics, Inc. (4)
- Janux Therapeutics, Inc. (3)
- Jounce Therapeutics, Inc. (5)
- Kadmon Holdings, Inc. (5)
- KalVista Pharmaceuticals, Inc. (5)
- Karuna Therapeutics, Inc. (3)
- Karyopharm Therapeutics Inc. (9)
- KBL MERGER CORP. IV (5)
- Keros Therapeutics, Inc. (3)
- Kezar Life Sciences, Inc. (3)
- Kindred Biosciences, Inc. (2)
- Kinnate Biopharma Inc. (2)
- Kiromic Biopharma, Inc. (3)
- KIWA BIO-TECH PRODUCTS GROUP CORP (5)
- Kodiak Sciences Inc. (4)
- Kronos Bio, Inc. (5)
- Krystal Biotech, Inc. (4)
- Kura Oncology, Inc. (2)
- Kymera Therapeutics, Inc. (5)
- LA JOLLA PHARMACEUTICAL CO (7)
- Lantern Pharma Inc. (2)
- LEAP THERAPEUTICS, INC. (1)
- Leisure Acquisition Corp. (6)
- LEXICON PHARMACEUTICALS, INC. (20)
- LifeSci Acquisition Corp. (6)
- Ligand Pharmaceuticals Incorporated (22)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (2)
- Locust Walk Acquisition Corp. (5)
- LogicBio Therapeutics, Inc. (2)
- LONGEVERON LLC (2)
- Lyell Immunopharma, Inc. (3)
- MACROGENICS INC (6)
- MADRIGAL PHARMACEUTICALS, INC. (15)
- Magenta Therapeutics, Inc. (4)
- MAIA Biotechnology, Inc. (2)
- MANHATTAN SCIENTIFICS INC (1)
- MANNKIND CORP (14)
- MARIZYME INC (18)
- Marker Therapeutics, Inc. (19)
- MATEON THERAPEUTICS INC (9)
- Matinas BioPharma Holdings, Inc. (3)
- MAXCYTE, INC. (2)
- MEDICINOVA INC (9)
- Medovex Corp. (1)
- MEI Pharma, Inc. (13)
- MERRIMACK PHARMACEUTICALS INC (3)
- Mersana Therapeutics, Inc. (6)
- Metacrine, Inc. (4)
- Millendo Therapeutics, Inc. (14)
- MiMedx Group, Inc. (23)
- Minerva Neurosciences, Inc. (8)
- MiNK Therapeutics, Inc. (3)
- MIRAGEN THERAPEUTICS, INC. (5)
- Mirati Therapeutics, Inc. (5)
- Mirum Pharmaceuticals, Inc. (9)
- Moderna, Inc. (13)
- Molecular Templates, Inc. (9)
- Moleculin Biotech, Inc. (2)
- Momenta Pharmaceuticals, Inc. (6)
- Monopar Therapeutics (5)
- Monte Rosa Therapeutics, Inc. (4)
- Morphic Holding, Inc. (5)
- MUSTANG BIO, INC. (5)
- Myovant Sciences Ltd. (3)
- Myriad Genetics, Inc. (12)
- NANOVIRICIDES, INC. (18)
- NantKwest, Inc. (3)
- Natera, Inc. (5)
- NAVIDEA BIOPHARMACEUTICALS, INC. (25)
- NEUROBIOLOGICAL TECHNOLOGIES INC (1)
- NEUROCRINE BIOSCIENCES INC (3)
- NEUROTROPE BIOSCIENCE, INC. (2)
- Neurotrope, Inc. (2)
- NEWLINK GENETICS CORP (18)
- NexImmune, Inc. (1)
- NextCure, Inc. (1)
- Nkarta, Inc. (5)
- NORTHWEST BIOTHERAPEUTICS INC (14)
- NOVAVAX INC (11)
- Novus Therapeutics, Inc. (7)
- NTN BUZZTIME INC (7)
- Nuo Therapeutics, Inc. (4)
- Nurix Therapeutics, Inc. (2)
- Nuvalent, Inc. (4)
- Nuvectis Pharma, Inc. (2)
- Ohr Pharmaceutical Inc (11)
- Olema Pharmaceuticals, Inc. (9)
- Olivia Ventures, Inc. (1)
- Omega Therapeutics, Inc. (3)
- OncBioMune Pharmaceuticals, Inc (9)
- OncoCyte Corp (3)
- Oncorus, Inc. (3)
- ONCOSEC MEDICAL Inc (9)
- OPGEN INC (11)
- Ophthotech Corp. (6)
- Opko Health, Inc. (8)
- ORAGENICS INC (23)
- Organicell Regenerative Medicine, Inc. (6)
- Organogenesis Holdings Inc. (2)
- ORGANOVO HOLDINGS, INC. (8)
- Orgenesis Inc. (2)
- Oric Pharmaceuticals, Inc. (4)
- Outlook Therapeutics, Inc. (3)
- Ovid Therapeutics Inc. (3)
- Oyster Point Pharma, Inc. (4)
- PALATIN TECHNOLOGIES INC (1)
- Pasithea Therapeutics Corp. (2)
- Passage BIO, Inc. (2)
- PDL BIOPHARMA, INC. (18)
- PepGen Inc. (3)
- Petra Acquisition Inc. (5)
- Pfenex Inc. (3)
- PharmaCyte Biotech, Inc. (9)
- PhaseBio Pharmaceuticals Inc (3)
- Phio Pharmaceuticals Corp. (6)
- PIERIS PHARMACEUTICALS, INC. (6)
- PLURISTEM THERAPEUTICS INC (15)
- PMV Pharmaceuticals, Inc. (3)
- POLARITYTE, INC. (19)
- PORTOLA PHARMACEUTICALS INC (6)
- Poseida Therapeutics, Inc. (4)
- Praxis Precision Medicines, Inc. (2)
- PRECISION BIOSCIENCES INC (4)
- Prelude Therapeutics Inc (5)
- PREMIER BIOMEDICAL INC (2)
- Prevail Therapeutics Inc. (2)
- Principia Biopharma Inc. (3)
- Progenics Pharmaceuticals, Inc. (5)
- PROGENITY, INC. (11)
- Prometheus Biosciences, Inc. (2)
- ProMIS Neurosciences Inc. (1)
- Propanc Biopharma, Inc. (3)
- Protagenic Therapeutics, Inc. (7)
- Protagonist Therapeutics, Inc (1)
- Protalix BioTherapeutics, Inc. (5)
- PROTEON THERAPEUTICS INC (6)
- PROTEOSTASIS THERAPEUTICS, INC. (2)
- ProtoKinetix, Inc. (1)
- PTC THERAPEUTICS, INC. (9)
- Pyxis Oncology, Inc. (2)
- Q BioMed Inc. (1)
- Qrons Inc. (1)
- Radius Health, Inc. (12)
- Rallybio Corp (2)
- RAPT Therapeutics, Inc. (4)
- Rasna Therapeutics Inc. (1)
- RECURSION PHARMACEUTICALS, INC. (4)
- Regeneron Pharmaceuticals (10)
- REGENERX BIOPHARMACEUTICALS INC (2)
- REGENXBIO Inc. (2)
- Regulus Therapeutics Inc. (9)
- Relay Therapeutics, Inc. (4)
- Reneo Pharmaceuticals, Inc. (4)
- RenovaCare, Inc. (4)
- RenovoRx, Inc. (1)
- Replimune Group, Inc. (7)
- Retrophin, Inc. (8)
- Revolution Medicines, Inc. (4)
- REXAHN PHARMACEUTICALS, INC. (10)
- Rezolute, Inc. (21)
- RHYTHM PHARMACEUTICALS, INC. (5)
- Rich Pharmaceuticals, Inc. (4)
- RIGEL PHARMACEUTICALS INC (14)
- RITTER PHARMACEUTICALS INC (22)
- ROCKET PHARMACEUTICALS, INC. (10)
- Rubius Therapeutics, Inc. (1)
- Sage Therapeutics, Inc. (5)
- Sana Biotechnology, Inc. (5)
- SANGAMO THERAPEUTICS, INC (17)
- Sarepta Therapeutics, Inc. (17)
- Savara Inc (12)
- Scholar Rock Holding Corp (1)
- SEATTLE GENETICS INC (13)
- SELECTA BIOSCIENCES INC (4)
- SELLAS Life Sciences Group, Inc. (7)
- Sensei Biotherapeutics, Inc. (2)
- SERA PROGNOSTICS, INC. (6)
- Seres Therapeutics, Inc. (6)
- Sesen Bio, Inc. (9)
- Shattuck Labs, Inc. (3)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Sierra Oncology, Inc. (3)
- Sigilon Therapeutics, Inc. (7)
- Silverback Therapeutics, Inc. (3)
- Social Capital Suvretta Holdings Corp. III (4)
- SOLENO THERAPEUTICS INC (9)
- Solid Biosciences Inc. (5)
- SOLIGENIX, INC. (4)
- SOPHIRIS BIO INC. (3)
- Sorrento Therapeutics, Inc. (29)
- Spectrum Pharmaceuticals, Inc. (6)
- Spero Therapeutics, Inc. (2)
- SPHERIX INC (8)
- Spinning Eagle Acquisition Corp. (5)
- Spring Bank Pharmaceuticals, Inc. (4)
- SpringWorks Therapeutics, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (6)
- SQZ Biotechnologies Co (2)
- Stellar Biotechnologies, Inc. (1)
- Stoke Therapeutics, Inc. (5)
- Sun BioPharma, Inc. (2)
- SUNESIS PHARMACEUTICALS INC (14)
- Surface Oncology, Inc. (4)
- SUTRO BIOPHARMA, INC. (4)
- Syndax Pharmaceuticals Inc (21)
- SYNLOGIC, INC. (5)
- Synthetic Biologics, Inc. (16)
- Syros Pharmaceuticals, Inc. (3)
- T2 Biosystems, Inc. (7)
- Talaris Therapeutics, Inc. (3)
- Taysha Gene Therapies, Inc. (3)
- TCR2 THERAPEUTICS INC. (3)
- TENAX THERAPEUTICS, INC. (29)
- Tenaya Therapeutics, Inc. (2)
- TG THERAPEUTICS, INC. (10)
- Therapeutics Acquisition Corp. (7)
- Tocagen Inc (7)
- Tonix Pharmaceuticals Holding Corp. (6)
- Tracon Pharmaceuticals, Inc. (2)
- Transcode Therapeutics, Inc. (4)
- Translate Bio, Inc. (2)
- TREVENA INC (8)
- Trovagene, Inc. (4)
- TScan Therapeutics, Inc. (3)
- Turning Point Therapeutics, Inc. (3)
- Twist Bioscience Corp (5)
- TYME TECHNOLOGIES, INC. (6)
- Tyra Biosciences, Inc. (2)
- U.S. Stem Cell, Inc. (8)
- Ultragenyx Pharmaceutical Inc. (17)
- Unicycive Therapeutics, Inc. (3)
- United Therapeutics Corp (3)
- Unity Biotechnology, Inc. (5)
- Unum Therapeutics Inc. (4)
- UroGen Pharma Ltd. (4)
- USA EQUITIES CORP. (1)
- VACCINEX, INC. (12)
- Vanda Pharmaceuticals Inc. (2)
- Vaxart, Inc. (9)
- Vaxcyte, Inc. (5)
- Vaxxinity, Inc. (5)
- VBI Vaccines Inc (2)
- Vera Therapeutics, Inc. (6)
- VERACYTE, INC. (7)
- Verastem, Inc. (10)
- Vericel Corp (10)
- Vertex Pharmaceuticals Inc (38)
- Verve Therapeutics, Inc. (3)
- VICAL INC (8)
- Vicapsys Life Sciences, Inc. (1)
- Viela Bio, Inc. (1)
- Vigil Neuroscience, Inc. (2)
- Viking Therapeutics, Inc. (14)
- Vir Biotechnology, Inc. (9)
- Virios Therapeutics, LLC (2)
- VistaGen Therapeutics, Inc. (3)
- VITAL THERAPIES INC (1)
- VITRO DIAGNOSTICS INC (15)
- Vor Biopharma Inc. (2)
- Voyager Therapeutics, Inc. (8)
- vTv Therapeutics Inc. (11)
- Werewolf Therapeutics, Inc. (2)
- WINDTREE THERAPEUTICS INC (21)
- XBiotech Inc. (1)
- Xencor Inc (5)
- Xenetic Biosciences, Inc. (5)
- Xenon Pharmaceuticals Inc. (2)
- Xilio Therapeutics, Inc. (2)
- XOMA Corp (12)
- YIELD10 BIOSCIENCE, INC. (12)
- ZAFGEN, INC. (11)
- Zai Lab Ltd (2)
- Zentalis Pharmaceuticals, LLC (4)
- ZIOPHARM ONCOLOGY INC (4)
- Zymeworks Inc. (3)
- Description of Common Stock (TENAX THERAPEUTICS, INC., Filed With SEC on March 28, 2024)
- Description of the Registrants Common Stock (Adagio Therapeutics, Inc., Filed With SEC on March 28, 2024)
- Stock Purchase Agreement, dated March 27, 2024, by and between Erasca, Inc. and each of the purchasers party thereto (Erasca, Inc., Filed With SEC on March 28, 2024)
- Description of Common Stock of the Registrant Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Cue Biopharma, Inc., Filed With SEC on March 28, 2024)
- Form of Amendment to Stock Option Agreement, dated December 30, 2023, between Eledon Pharmaceuticals, Inc. and David-Alexandre C. Gros, M.D., Steve Perrin, Ph D. and Paul Little (Novus Therapeutics, Inc., Filed With SEC on March 28, 2024)
- Form of Stock Option Agreement, dated May 1, 2023, between Eledon Pharmaceuticals, Inc. and each of David-Alexandre C. Gros, M.D., Steve Perrin, Ph D. and Paul Little (Novus Therapeutics, Inc., Filed With SEC on March 28, 2024)
- Form of Restricted Stock Unit Grant Notice and Award Agreement under the Vera Therapeutics, Inc. 2024 Inducement Plan (Vera Therapeutics, Inc., Filed With SEC on March 27, 2024)
- Forms of Stock Option Grant Notice, Stock Option Agreement and Notice of Exercise under the Vera Therapeutics, Inc. 2024 Inducement Plan (Vera Therapeutics, Inc., Filed With SEC on March 27, 2024)
- Description of Common Stock of the Registrant (Vera Therapeutics, Inc., Filed With SEC on March 27, 2024)
- Q32 Bio Inc. 2024 Employee Stock Purchase Plan (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- Form of Employee Stock Option Agreement (BioAtla, Inc., Filed With SEC on March 26, 2024)
- Form of Non-Employee Director Stock Option Agreement (BioAtla, Inc., Filed With SEC on March 26, 2024)
- Form of Common Stock Certificate of Marker Therapeutics, Inc (Marker Therapeutics, Inc., Filed With SEC on March 26, 2024)
- Description of Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934 (Stoke Therapeutics, Inc., Filed With SEC on March 25, 2024)
- Form of Restricted Stock Unit Agreement with Officers (LEXICON PHARMACEUTICALS, INC., Filed With SEC on March 25, 2024)
- 2024 Employee Stock Purchase Plan (Graphite Bio, Inc., Filed With SEC on March 22, 2024)
- Description of Capital Stock (Nkarta, Inc., Filed With SEC on March 21, 2024)
- Dianthus Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Magenta Therapeutics, Inc., Filed With SEC on March 21, 2024)
- Description of Capital Stock (ALPINE IMMUNE SCIENCES, INC., Filed With SEC on March 20, 2024)
- Description of Capital Stock of the Company (ProtoKinetix, Inc., Filed With SEC on March 20, 2024)
- Description of the Registrants Common Stock (Design Therapeutics, Inc., Filed With SEC on March 19, 2024)
- Stock Purchase and Option Agreement dated December 29, 2023 by and between the Investors and ImmunityBio, Inc (NantKwest, Inc., Filed With SEC on March 19, 2024)
- Description of Common Stock of the Registrant (Mirum Pharmaceuticals, Inc., Filed With SEC on March 15, 2024)
- Form of Restricted Stock Unit Inducement Award for issuances under the Restated 2020 Plan (NTN BUZZTIME INC, Filed With SEC on March 14, 2024)
- Form of Stock Option Inducement Award for issuances under the Restated 2020 Plan (NTN BUZZTIME INC, Filed With SEC on March 14, 2024)
- Form of Restricted Stock Unit Inducement Award for issuances under the 2021 Inducement Plan (NTN BUZZTIME INC, Filed With SEC on March 14, 2024)
- Form of Stock Option Inducement Award for issuances under the 2021 Inducement Plan (NTN BUZZTIME INC, Filed With SEC on March 14, 2024)
- DESCRIPTION OF COMMON STOCK (Vaxart, Inc., Filed With SEC on March 14, 2024)
- Form of Restricted Stock Unit Award Agreement (Cullinan Oncology, LLC, Filed With SEC on March 14, 2024)
- Amended Restricted Stock Unit Grant Notice by and between the Registrant and Elizabeth Barrett, dated as of December 20, 2023 (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
- Amendment to Form of Restricted Stock Unit Grant Notice under the UroGen Pharma Ltd. 2019 Inducement Plan (UroGen Pharma Ltd., Filed With SEC on March 14, 2024)
- Form of Officer Inducement Award Stock Option (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Non-Qualified Stock Option Grant Notice and Award Agreement (ZAFGEN, INC., Filed With SEC on March 14, 2024)
- Description of Common Stock of the Registrant (aTYR PHARMA INC, Filed With SEC on March 14, 2024)
- Description of Capital Stock (Protalix BioTherapeutics, Inc., Filed With SEC on March 14, 2024)
- Amended and Restated 2021 Employee Stock Purchase Plan (Solid Biosciences Inc., Filed With SEC on March 13, 2024)
- Description of Capital Stock (vTv Therapeutics Inc., Filed With SEC on March 13, 2024)
- Amendment to Common Stock Purchase Warrants (Emerald Bioscience, Inc., Filed With SEC on March 13, 2024)
- Description of Capital Stock (SANGAMO THERAPEUTICS, INC, Filed With SEC on March 13, 2024)
- 2020 Employee Stock Purchase Plan, as amended (Black Diamond Therapeutics, Inc., Filed With SEC on March 12, 2024)